Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: [18F]F-DOPA Imaging in Patients With Autonomic Failure [Phase 1]

View source ↗

Summary

Phase 1 imaging trial of [18F]F-DOPA in autonomic failure syndromes (including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies) is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • [18F]F-DOPA (fluorodopa)

Snippet

Sponsor: Daniel Claassen | Conditions: Autonomic Failure, Pure Autonomic Failure | Phase 1 | Status: RECRUITING